B. Braun Medical Inc. has initiated a voluntary North American recall of one lot of its Excel® Lactated Ringers Injection, 1000mL, distributed to hospital and healthcare facilities. The recall, announced on August 19, 2026, is due to the presence of particulate matter, primarily identified as cellulose cotton fibers, along with cellulose wood fiber and polystyrene.
The company's risk assessment indicates that using the affected product could reasonably lead to serious health consequences. Potential risks include pulmonary emboli, blockages in other blood vessels causing tissue death and organ damage, and phlebitis.
Furthermore, foreign particles infused intravenously may activate the immune system, cause organ dysfunction, and lead to hemolysis. Despite these potential dangers, B. Braun has not yet received any reports of adverse events linked to this specific recall.